Search Results - "Aluisio, L"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Histamine H3 receptor antagonists: from target identification to drug leads by Bonaventure, P, Letavic, M, Dugovic, C, Wilson, S, Aluisio, L, Pudiak, C, Lord, B, Mazur, C, Kamme, F, Nishino, S, Carruthers, N, Lovenberg, T

    Published in Biochemical pharmacology (15-04-2007)
    “…The successful cloning and functional expression of the histamine H(3) receptor in the late 1990 s has greatly facilitated our efforts to identify small…”
    Get full text
    Journal Article
  2. 2

    Acute wake‐promoting actions of JNJ‐5207852, a novel, diamine‐based H 3 antagonist by Barbier, A J, Berridge, C, Dugovic, C, Laposky, A D, Wilson, S J, Boggs, J, Aluisio, L, Lord, B, Mazur, C, Pudiak, C M, Langlois, X, Xiao, W, Apodaca, R, Carruthers, N I, Lovenberg, T W

    Published in British journal of pharmacology (17-02-2009)
    “…1‐[4‐(3‐piperidin‐1‐yl‐propoxy)‐benzyl]‐piperidine (JNJ‐5207852) is a novel, non‐imidazole histamine H 3 receptor antagonist, with high affinity at the rat (p…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Acute wake‐promoting actions of JNJ‐5207852, a novel, diamine‐based H3 antagonist by Barbier, A J, Berridge, C, Dugovic, C, Laposky, A D, Wilson, S J, Boggs, J, Aluisio, L, Lord, B, Mazur, C, Pudiak, C M, Langlois, X, Xiao, W, Apodaca, R, Carruthers, N I, Lovenberg, T W

    Published in British journal of pharmacology (01-11-2004)
    “…1‐[4‐(3‐piperidin‐1‐yl‐propoxy)‐benzyl]‐piperidine (JNJ‐5207852) is a novel, non‐imidazole histamine H3 receptor antagonist, with high affinity at the rat…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Histamine H 3 receptor antagonists: From target identification to drug leads by Bonaventure, P., Letavic, M., Dugovic, C., Wilson, S., Aluisio, L., Pudiak, C., Lord, B., Mazur, C., Kamme, F., Nishino, S., Carruthers, N., Lovenberg, T.

    Published in Biochemical pharmacology (15-04-2007)
    “…The successful cloning and functional expression of the histamine H 3 receptor in the late 1990s has greatly facilitated our efforts to identify small…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetics and pharmacodynamics of norfluoxetine in rats: Increasing extracellular serotonin level in the frontal cortex by Qu, Ying, Aluisio, Leah, Lord, Brian, Boggs, Jamin, Hoey, Kenway, Mazur, Curt, Lovenberg, Timothy

    Published in Pharmacology, biochemistry and behavior (01-05-2009)
    “…Norfluoxetine is the most important active metabolite of the widely used antidepressant fluoxetine. Although the pharmacokinetics/pharmacodynamics (PK/PD)…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Novel substituted 4-phenyl-[1,3]dioxanes: potent and selective orexin receptor 2 (OX 2R) antagonists by McAtee, Laura C, Sutton, Steven W, Rudolph, Dale A, Li, Xiaobing, Aluisio, Leah E, Phuong, Victor K, Dvorak, Curt A, Lovenberg, Timothy W, Carruthers, Nicholas I, Jones, Todd K

    Published in Bioorganic & medicinal chemistry letters (16-08-2004)
    “…A series of novel, selective orexin receptor 2 antagonists consisting of substituted 4-phenyl-[1,3]dioxanes is reported (e.g. 9). Orexins, also termed…”
    Get full text
    Journal Article
  14. 14
  15. 15